Eficacia de un apósito autoadhesivo de poliuretano para prevenir la formación de cicatrices hipertróficas

Abstract

Our goal is to evaluate the efficacy of a polyurethane self-adhesive dressing in preventing hypertrophic scars in a group of patients undergoing breast reduction surgery. After the initial wound healing period, all patients were submitted to the preventive procedure with compression and adhesive dressing: 66 patients (35.6±10.8 years old) used Trofolastin® reduction scar as adhesive (subjects) and 47 patients (38.7±12 years old) were treated with other adhesives (controls). In the control group, 23.4% of patients presented hypertrophic scars, whereas this percentage was only 9.1% in subjects (p<0.05). Moreover, 27 patients of the control group (56.5%) presented scars with a Vancouver score equal or higher than 4 in contrast with only 6 cases (9.1%) in the group of subjects (p<0.0001). In conclusion, the prophylactic use of Trofolastin® reduction scar, once the initial wound healing period is complete, significantly reduces the risk of hypertrophic scars (relative risk 6.32 [95% CI 2.83-14.09], according the Fisher's exact test).